ResMed Inc. (RMD)
NYSE: RMD · Real-Time Price · USD
211.94
-11.30 (-5.06%)
At close: Aug 7, 2026, 4:00 PM EDT
212.00
+0.06 (0.03%)
After-hours: Aug 7, 2026, 7:50 PM EDT

ResMed Stock Forecast

Stock Price Forecast

According to 18 analysts polled by S&P Global, ResMed stock has a consensus rating of "Buy" and an average price target of $247.87. The average 1-year stock price forecast is 16.95% higher than the current stock price, while the lowest is $175 (-17.43%) and the highest is $325 (+53.35%).

Price Target: $247.87 (+16.95%)
Analyst Consensus: Buy

Price Target

Chart
TargetLowAverageMedianHigh
Price$175$247.87$235$325
Change-17.43%+16.95%+10.88%+53.35%

Analyst Ratings

The average analyst rating for ResMed stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

Chart
RatingMar '26Apr '26May '26Jun '26Jul '26Aug '26
Strong Buy878866
Buy332111
Hold77781010
Sell000000
Strong Sell111111
Total191818181818

Latest Forecasts

AnalystFirmRatingRatingActionPrice TargetUpsideDate
Unknown Analyst
Oppenheimer
No rating
Oppenheimer
Hold
Reiterates
n/a
HoldReiteratesn/an/aAug 8, 2026
Piper Sandler
Piper Sandler
Hold
Maintains
$225
HoldMaintains$225+6.16%Aug 7, 2026
Robert W. Baird
Robert W. Baird
Hold
Maintains
$217$213
HoldMaintains$217$213+0.50%Aug 7, 2026
RBC Capital
RBC Capital
Hold
Maintains
$234$244
HoldMaintains$234$244+15.13%Aug 7, 2026
KeyBanc
KeyBanc
Buy
Maintains
$260$255
BuyMaintains$260$255+20.32%Aug 7, 2026
More Analyst Ratings

Financial Forecast

Revenue This Year
5.99B
from 5.65B
Increased by 6.03%
Revenue Next Year
6.44B
from 5.99B
Increased by 7.35%
EPS This Year
12.08
EPS Next Year
13.25
from 12.08
Increased by 9.64%
Fiscal YearFY 2022FY 2023FY 2024FY 2025FY 2026FY 2027
Period EndingJun 30, 2022Jun 30, 2023Jun 30, 2024Jun 30, 2025Jun 30, 2026Jun 30, 2027
Revenue
3.58B4.22B4.69B5.15B5.65B5.99B
Revenue Growth
11.93%18.02%10.95%9.84%9.85%6.03%
Gross Profit
2.06B2.39B2.69B3.09B3.48B3.77B
Gross Margin
57.68%56.50%57.38%59.99%61.62%62.82%
Operating Income
1.00B1.15B1.38B1.69B1.92B2.21B
Net Income
779.44M897.56M1.02B1.40B1.52B1.61B
EPS
-----12.08
Forward PE
34.1030.8222.8625.3216.4417.54
Dividend / Share
1.681.761.922.122.402.62
Dividend Growth
-4.76%9.09%10.42%13.21%9.25%
Free Cash Flow
127.68M400.59M1.18B1.21B939.25M1.56B
No. Analysts
-----7
EPS and Forward PE are based on non-GAAP adjusted numbers.

Revenue Forecast

Revenue202720282029
High6.2B
Avg6.0B
Low5.8B

Revenue Growth

Revenue Growth202720282029
High
9.9%
Avg
6.0%
Low
2.0%

EPS Forecast

EPS202720282029
High12.44
Avg12.08
Low11.91

EPS Growth

EPS Growth202720282029
High
30.3%
Avg
26.5%
Low
24.8%